Recommended Peptide Stacks

BPC-157 and TB-500 target healing from two complementary angles. BPC-157 drives localised vascular repair and connective tissue regeneration, while TB-500 mobilises stem cells systemically to accelerate recovery. MGF (at Mid and Premium tiers) then activates satellite cells specifically in damaged muscle fibres, directing the repair response precisely where it is needed.

Safety Note

A well-researched combination with a favourable safety profile across preclinical and early clinical use. Side effects are typically mild and transient, including minor injection site reactions and occasional mild fatigue in the first week.

CJC-1295 with DAC provides a sustained GH baseline lasting 6 to 8 days per injection. GHRP-2 amplifies natural GH pulses with minimal appetite stimulation. At the Premium tier, IGF-1 LR3 converts elevated GH into direct anabolic signalling at the muscle, completing the GH axis protocol for experienced users.

Safety Note

Entry and Mid tiers are well-tolerated. The Premium tier is designed for experienced users and combines multiple GH-axis compounds simultaneously. Bloodwork prior to starting the Premium tier is strongly recommended.

Usage Advisory

The Premium tier combines CJC-1295 DAC and GHRP-2 with direct IGF-1 LR3, stimulating the GH/IGF-1 axis from multiple angles simultaneously. This is the most advanced configuration and should only be used by individuals who have completed at least one cycle of the Entry or Mid tier. An IGF-1 baseline blood test before starting is strongly advised. Individuals with any history of cancer, unscreened tumours, or uncontrolled blood sugar should not proceed to the Premium tier.

Month 1 (fat phase): HGH Fragment 176-191 targets fat cells specifically without systemic GH effects. Ipamorelin adds a clean GH pulse with minimal side effects. Month 2 (anabolic phase): Once the substrate is leaner, IGF-1 LR3 and CJC-1295 DAC drive direct muscle anabolism on the improved body composition foundation.

Safety Note

The phased structure is what makes this protocol safe. Fat-burning and anabolic components are run sequentially rather than simultaneously, eliminating potential hormonal or glucose conflicts between phases.

The GLP-1 receptor agonist suppresses appetite and improves insulin sensitivity at the hormonal level. AOD-9604 directly stimulates lipolysis in adipose tissue at the cellular level. L-Carnitine shuttles released fatty acids into mitochondria for energy, ensuring freed fat is burned rather than redeposited.

Safety Note

Entry and Mid tiers are safe for healthy adults. The Premium tier includes Tesamorelin alongside a triple GLP-1/GIP/Glucagon agonist (Retatrutide), which requires medical clearance for individuals with blood sugar conditions.

Usage Advisory

The Premium tier combines Retatrutide (which lowers blood glucose) with Tesamorelin (which raises GH and can elevate blood glucose). For individuals with diabetes, insulin resistance, or on blood sugar medication, this combination may produce unpredictable glucose fluctuations and medical supervision is required before use. Healthy individuals without blood sugar concerns can use this protocol safely.

Month 1 to 2 (fat loss phase): GLP-1 agonist drives significant fat reduction, with AOD-9604 enhancing lipolysis at the cellular level. Month 3 onwards (skin phase): GHK-Cu triggers collagen synthesis and dermal remodelling to address loose skin from rapid fat loss. AHK-Cu adds scalp and follicle recovery, while BPC-157 repairs the connective tissue layer beneath.

Safety Note

One of the strongest stacks from a safety standpoint. GLP-1 and skin peptide mechanisms operate in completely separate biological pathways, and the phased structure ensures no interaction. All skin-phase components carry excellent safety profiles.

Epithalon activates telomerase to slow cellular ageing at the DNA level. NAD+ restores mitochondrial energy production that naturally declines with age. GHK-Cu reverses dermal collagen loss and modulates over 4,000 genes involved in repair and anti-inflammation. At the Premium tier, Thymalin and Thymosin Alpha-1 restore thymic immune function, one of the most important and underaddressed longevity pathways.

Safety Note

A well-studied combination targeting multiple distinct hallmarks of ageing simultaneously. NAD+ and GHK-Cu synergise through cellular energy and structural repair pathways with no adverse interactions identified.

GHK-Cu is the most extensively studied injectable skincare peptide. It activates collagen synthesis, reduces inflammation, and modulates gene expression at the epigenetic level. AHK-Cu adds targeted follicle and scalp repair. Snap-8 relaxes expression lines from within. Matrixyl stimulates collagen and hyaluronic acid production. At the Premium tier, BPC-157 addresses the vascular and connective tissue layer beneath the skin.

Safety Note

The safest stack in the Striata range. All components operate on complementary skin and collagen synthesis pathways with no clinically significant interactions. Well-tolerated across all three tiers.

Semax drives BDNF and neuroplasticity for enhanced focus and memory consolidation. Selank modulates cortisol and reduces anxiety without sedation. Injectable Melatonin resets the circadian rhythm for deep restorative sleep. NAD+ restores the cellular energy needed for neurological repair. Pinealon supports the pineal gland's circadian regulation at the upstream hormonal level.

Safety Note

Entry and Mid tiers are well-tolerated. The Premium tier should be taken exclusively before bed due to the combined sedative and circadian-resetting effects of Melatonin, Selank, and Pinealon taken together.

Usage Advisory

The Premium tier must be administered before bed only. The combination of injectable Melatonin (10mg), Selank's anxiolytic effect, and Pinealon's sleep-promoting activity creates significant sedation. Do not drive or operate machinery after administering the Premium tier. A half-dose in the first week is advisable to assess individual sensitivity before progressing to the full protocol.

Month 1 (immune activation): Thymosin Alpha-1 activates T-cells and dendritic cells acutely. BPC-157 reduces systemic inflammation that suppresses immune response, clearing the environment for effective immune rebuilding. Month 2 (maintenance): Thymalin restores thymic peptide production for sustained immune competence. Epithalon and NAD+ provide the cellular longevity and energy substrate needed to maintain these gains.

Safety Note

Mechanistically one of the strongest stacks in the range. Each component targets a distinct and complementary aspect of immune function. The phased structure allows the inflammatory environment to clear in Month 1 before longer-term thymic restoration begins in Month 2.

Month 1 (foundation): CJC-1295 DAC establishes a sustained GH baseline. GHRP-2 amplifies GH pulses. The BPC+TB Wolverine Stack clears existing tissue damage. You cannot build muscle efficiently on unresolved injuries. Month 2 (amplification): IGF-1 LR3 and MGF deliver direct anabolic signalling to primed, healthy muscle tissue. The sequencing is the key: repair first, build second.

Safety Note

Entry and Mid tiers are safe for healthy adults with training experience. The Premium tier is the most advanced GH protocol in the Striata range and is intended for experienced users only. Pre-cycle bloodwork is strongly recommended.

Usage Advisory

The Premium tier's Month 2 phase combines CJC-1295 DAC, GHRP-2, IGF-1 LR3, and MGF, stimulating the GH/IGF-1 axis from multiple directions simultaneously. This is reserved for experienced users who have already completed at least one Entry or Mid cycle. An IGF-1 blood panel (including fasting glucose and insulin) before beginning Month 2 is strongly advised. Not suitable for anyone with a history of cancer, active cancer, or unscreened tumours.